The Alzheimer’s Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement

INTRODUCTION: The overall goal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer’s disease (AD) clinical trials. ADNI-3, beginning August 1, 2016, is a five year renewal of the current ADNI-2 study. METHODS: ADNI-3 will follow current and additional su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Weiner, Michael W., Veitch, Dallas P., Aisen, Paul S., Beckett, Laurel A., Cairns, Nigel J., Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Morris, John C., Petersen, Ronald C., Salazar, Jennifer, Saykin, Andrew J., Shaw, Leslie M, Toga, Arthur W., Trojanowski, John Q.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536850/
https://ncbi.nlm.nih.gov/pubmed/27931796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2016.10.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados